Chromatin Remodelers as Players and Drivers in Pathological States

Dear Colleagues,

I would like to draw our attention to chromatin remodelers, particularly their role and contribution to the development of pathological states, such as cancer.

Indeed, it is known that proteins such as INO80, CHD7, or RSF1 participate in the regulation of oncogenes at different levels, mainly through the recruitment of other mediators and, therefore, their overexpression in different human tissues. On the other hand, some of them are considered tumor suppressors, such as HLTF or ZRANB3, since they bypass DNA damage or stimulate damage repair. Of note, SMARCAL1 from the same SNF2 family was recently characterized as a dual agent in cancer cells, underscoring its multipurpose and critical involvement in maintaining genome stability and regulating the cell cycle.

While this information goes a long way toward understanding how these proteins are regulated or actively regulate disease processes, there is still much to discover. The lack of sufficient structural and functional data and information at the cellular level impedes our understanding of their mechanistic effects on the development of this pathology.

This Special Issue aims to broaden current knowledge on this topic and constitutes an opportunity to gather the latest results obtained by experts in the field, which could potentially aid the design of new diagnostic and therapeutic tools.

Dr. Matteo De March
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.